NYSEMKT: SRXHSrx Health Solutions Inc Stock
$0.32+0.00 (+0%)
Updated Oct 17, 2025
SRXH Price
$0.32
Fair Value Price
N/A
Market Cap
$7.93M
52 Week Low
$0.27
52 Week High
$2.67
P/E
-0.21x
P/B
-0.17x
P/S
0.33x
PEG
N/A
Dividend Yield
N/A
Revenue
$37.14M
Earnings
-$16.09M
Gross Margin
34.8%
Operating Margin
-45.29%
Profit Margin
-43.3%
Debt to Equity
-1.74
Operating Cash Flow
-$18M
Beta
0.86
Next Earnings
Nov 10, 2025
Ex-Dividend
N/A
Next Dividend
N/A
SRXH Overview
Better Choice Company Inc. offers kibble and canned dog and cat foods, freeze-dried raw dog foods and treats, vegan dog foods and treats, oral care products, as well as chews and grooming products. Its brands are Halo and TruDog. Better Choice primarily sells its products online. Better Choice was founded in 1986 and is based in Tampa, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SRXH's potential to beat the market
- SRXH doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
SRXH
RankedUnranked of 41
RankedUnranked of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.86 | A | |
| $16.45 | A | |
| $14.63 | A |
Be the first to know about important SRXH news, forecast changes, insider trades & much more!
SRXH News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SRXH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SRXH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SRXH is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
SRXH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more SRXH due diligence checks available for Premium users.
Valuation
SRXH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.21x
Industry
17.2x
Market
37.42x
SRXH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.17x
Industry
5.08x
SRXH's financial health
Profit margin
Revenue
$11.4M
Net Income
-$15.1M
Profit Margin
-132.2%
SRXH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SRXH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$34.0M
Liabilities
$79.9M
Debt to equity
-1.74
SRXH's short-term liabilities ($74.11M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SRXH's short-term assets ($24.53M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SRXH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SRXH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$15.0M
Investing
$15.2M
Financing
$4.1M
SRXH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SRXH vs Medical Care Facility Stocks
Srx Health Solutions Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.